SLC26A3

Chloride anion exchanger · P40879 · SLC26A3 on Sugi Atlas →

655 patent compounds predicted against SLC26A3, 237 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL24045105 SCHEMBL24045105 1.00 10/20
SCHEMBL26687589 SCHEMBL26687589 1.00 10/20
SCHEMBL30154899 SCHEMBL30154899 1.00 10/20
SCHEMBL24045265 SCHEMBL24045265 0.81 10/20
SCHEMBL24045264 SCHEMBL24045264 0.79 10/20
SCHEMBL743580 SCHEMBL743580 0.77 10/20
SCHEMBL24045333 SCHEMBL24045333 0.73 10/20
SCHEMBL26687628 SCHEMBL26687628 0.73 10/20
SCHEMBL24045268 SCHEMBL24045268 0.79 9/20
SCHEMBL24045240 SCHEMBL24045240 0.69 9/20
SCHEMBL24045106 SCHEMBL24045106 1.00 8/20
SCHEMBL26687854 SCHEMBL26687854 0.82 8/20
SCHEMBL24045273 SCHEMBL24045273 0.84 7/20
SCHEMBL24045277 SCHEMBL24045277 0.83 7/20
SCHEMBL26687910 SCHEMBL26687910 0.82 7/20
SCHEMBL24045275 SCHEMBL24045275 0.78 7/20
SCHEMBL24045255 SCHEMBL24045255 0.71 7/20
SCHEMBL6559983 SCHEMBL6559983 0.43 7/20
SCHEMBL24045270 SCHEMBL24045270 0.74 6/20
SCHEMBL24045271 SCHEMBL24045271 0.74 6/20

Clinical trials — most relevant to SLC26A3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS) PHASE4COMPLETED
Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation PHASE2/PHASE3UNKNOWN
Secretin in Ex-situ Liver Perfusion PHASE1/PHASE2ENROLLING_BY_INVITATION
CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops PHASE2UNKNOWN
Effect of, OAT3, on the Renal Secretion of Cefotaxime PHASE1COMPLETED
Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters EARLY_PHASE1COMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
Oxalate and Citrate in Humans - Response to Citrate nanRECRUITING
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts nanCOMPLETED
Clinical Phenotypic Characteristics of SC26A4 nanUNKNOWN
SLC13A5 Deficiency Natural History Study - Remote Only nanENROLLING_BY_INVITATION
Comparison Between Ultra-low-dose Computed Tomography and Lung MRI in Cystic Fibrosis nanCOMPLETED
Gene Expression in Inflammatory Bowel Disease nanENROLLING_BY_INVITATION
Genotype-phenotype Correlation of SLC26A4 in CI Patients With EVA nanUNKNOWN
Bronchial Trans-epithelial Transport in Patients With Idiopathic Multiple Dilations of the Bronchi nanCOMPLETED
Oxalate and Citrate nanRECRUITING
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital nanUNKNOWN
The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects nanCOMPLETED
Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter nanCOMPLETED
Impact of Polymorphisms of OAT1, OAT3, and OCT2 on Transportation of Potential Nephrotoxic Drugs nanCOMPLETED
Bile Acid Effects in Fetal Arrhythmia Study nanUNKNOWN
Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes nanRECRUITING
Gastrostomy-Biliary Diversion: Innovative Management for Bile Canalicular Transport Disorders nanUNKNOWN
Comparative Effects of Mechanical and Manual Airway Clearance Techniques in Cystic Fibrosis nanNOT_YET_RECRUITING
POTASSIUM-RICH SALT SUBSTITUTES IN KIDNEY TRANSPLANT RECIPIENTS nanNOT_YET_RECRUITING
Muscle Endurance in Children With Cystic Fibrosis nanCOMPLETED
ADPKD Alterations in Hepatic Transporter Function nanCOMPLETED
Sweat Response, Sweat Composition and Thermoregulatory Response to Exercise in Heat in Adults With Cystic Fibrosis on Modulator Therapy. nanUNKNOWN
A Prospective Study of Advanced Diagnostics in People With an Unclear Diagnosis of Cystic Fibrosis nanNOT_YET_RECRUITING
Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant Patients nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC26A3 binder may also engage these)

ProteinNameSimilarity
Q924C9 0.998 Q924C9 →
Q9WVC8 0.997 Q9WVC8 →
Q69DJ1 0.990 Q69DJ1 →
P50443 0.986 P50443 →
Q9BEG8 0.985 Q9BEG8 →
Q7T2C4 0.985 Q7T2C4 →
Q9EPH0 0.983 Q9EPH0 →
Q65AC2 0.983 Q65AC2 →
P58743 0.982 P58743 →
Q62273 0.981 Q62273 →
Q9GJY3 0.980 Q9GJY3 →
Q99NH7 0.980 Q99NH7 →
O70531 0.979 O70531 →
Q9LW86 0.979 Q9LW86 →
Q9MAX3 0.978 Q9MAX3 →
Q9JKQ2 0.978 Q9JKQ2 →
D7PC76 0.978 D7PC76 →
Q8GYH8 0.977 Q8GYH8 →
O04289 0.977 O04289 →
O04722 0.976 O04722 →
A0FKN5 0.976 A0FKN5 →
P53391 0.975 P53391 →
Q8BU91 0.974 Q8BU91 →
P53393 0.973 P53393 →
Q94LW6 0.973 Q94LW6 →
Q8CIW6 0.972 Q8CIW6 →
P53392 0.971 P53392 →
Q9FEP7 0.971 Q9FEP7 →
Q9SAY1 0.968 Q9SAY1 →
Q7LBE3 0.968 Q7LBE3 →